Article

Real-time benefits verification assists practice management

pVerify's Vision Benefits API allows front-office staff to handle vision eligibility verifications seamlessly in their own EHR.

pVerify is adding real-time vision benefits verification to its list of solutions that combine technology with human-enabled AI to replace the manual processes of front-office staff, radically lowering labor costs while providing price transparency.

In the past, to verify a patient’s vision benefits required front-office staff to make phone calls and juggle passwords for individual websites, tasks often given to entry-level staff. pVerify's new Vision Benefits API allows VSP and EyeMed plans to be processed and returned in under 30 seconds, either in the pVerify Provider Portal or within company's EHR system through API Connection.

Real-time VSP and EyeMed Verification are included in the initial release; more vision payers, including Spectera, Davis and many others, will be added throughout the remainder of 2021.

"With the launch of our all-new Vision Benefits API, pVerify becomes the only company that offers real-time Medical, Dental and Vision verification APIs to the healthcare industry," said Jay Nitturkar, pVerify's CEO, in a statement.

According to the company, pVerify's HIPAA-complaint, SaaS offering includes fully-customizable eligibility portal, robust set of REST APIs, and mobile SDKs that power mission-critical, front-end eligibility process solutions for leading software companies as well as ambulatory practices in the healthcare sector.

The company also released a case study outlining how a 100+ location ophthalmology group solved complex billing issues and created price transparency while saving over $1.3 million in labor costs and navigating the fluctuation trends of IPAs in California.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Jason Bacharach, MD, on early-onset efficacy with perfluorohexyloctane in dry eye
(Image credit: Ophthalmology Times) CCOI's new CEO Malvina Eydelman, MD, outlines her mission and vision for the organization
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
© 2025 MJH Life Sciences

All rights reserved.